$3.53
0.030.86%
Last update: Nov 4, 9:15 AM
LENZ Therapeutics Inc (LENZ) Stock Price, Quote, News & History
LENZNASDAQ
LENZ Therapeutics partners with Arrotex to commercialize VIZZ in Australia and New Zealand as analysts remain focused on U.S. growth.
You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.
Other companies in LENZ Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
LENZ Therapeutics has a consensus price target of $29.13.
The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $3.53 last updated November 4, 2026 at 9:15 AM EST.
There are no upcoming dividends for LENZ Therapeutics.
LENZ Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for LENZ Therapeutics.
LENZ Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a...
